World's Best Scientists 2026 revealed!
Claudio Bordignon

Claudio Bordignon

D-Index & Metrics

Immunology

D-Index
82
Citations
29281
World Ranking
1487
National Ranking
58

Medicine

D-Index
82
Citations
29370
World Ranking
15962
National Ranking
627

Research.com Recognitions

  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)

Overview

Claudio Bordignon is affiliated with MolMed in Italy and conducts research primarily within the field of Medicine, with a focus on Genetics, Neurology, Oncology, Molecular Biology, and Pathology and Forensic Medicine. Their scholarly output includes studies concerning diagnosis and treatment of central nervous system (CNS) lymphomas and gliomas, as well as investigations into CAR-T cell therapy and virus-based gene therapy.

The main topics addressed in their work are:

  • CNS Lymphoma Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • CAR-T cell therapy research
  • Virus-based gene therapy research
  • Viral Infectious Diseases and Gene Expression in Insects
  • Lymphoma Diagnosis and Treatment
  • Brain Metastases and Treatment

Bordignon has collaborated frequently with several coauthors, including Andrés J.M. Ferreri, Teresa Calimeri, Maurilio Ponzoni, Flavio Curnis, and Gian Marco Conte. These partnerships have contributed to the advancement of various oncology and immunology topics.

Their publication venues are diverse and include:

  • Frontiers in Immunology
  • Blood Advances
  • SSRN Electronic Journal
  • Molecular Biology Reports
  • Journal of Geriatric Oncology

Among their recent papers are:

  • "CAR T Cells Redirected to CD44v6 Control Tumor Growth in Lung and Ovary Adenocarcinoma Bearing Mice," published in Frontiers in Immunology in 2020
  • "Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial," published in Blood Advances in 2020
  • "Blood-Brain Barrier Permeabilization with Engineered Tumor Necrosis Factor-α Followed by R-CHOP Is an Active and Safe Salvage Therapy in Primary CNS Lymphoma," published in SSRN Electronic Journal in 2020
  • "Impact of Ilex paraguariensis extract on osteoblastic phenotype expression," published in Molecular Biology Reports in 2025
  • "Evaluation of treatment strategies for colorectal cancer in older adults: A scoping review of observational studies," published in Journal of Geriatric Oncology in 2025

Claudio Bordignon is recognized as a member of the European Molecular Biology Organization (EMBO), reflecting affiliation with a prominent scientific community in molecular biology.

Best Publications

  • HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-Leukemia

    Chiara Bonini;Giuliana Ferrari;Simona Verzeletti;Paolo Servida

  • Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative Conditioning

    Alessandro Aiuti;Shimon Slavin;Memet Aker;Francesca Ficara

  • Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy.

    Alessandra Biffi;Eugenio Montini;Laura Lorioli;Martina Cesani

  • Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells

    Margherita Norelli;Barbara Camisa;Giulia Barbiera;Laura Falcone

  • Type 1 T regulatory cells.

    Maria Grazia Roncarolo;Rosa Bacchetta;Claudio Bordignon;Satwant Narula

  • Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency

    Alessandro Aiuti;Federica Cattaneo;Stefania Galimberti;Ulrike Benninghoff

  • Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients

    Claudio Bordignon;Luigi D. Notarangelo;Nadia Nobili;Giuliana Ferrari

  • Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs.

    Maurilio Sampaolesi;Stephane Blot;Giuseppe D'antona;Nicolas Granger

  • IL-7 and IL-15 instruct the generation of human memory stem T cells from naïve precursors

    Nicoletta Cieri;Barbara Camisa;Fabienne Cocchiarella;Mattia Forcato

  • Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation

    Luca Vago;Serena Kimi Perna;Monica Zanussi;Benedetta Mazzi

  • Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer

    Elena Provasi;Pietro Genovese;Angelo Lombardo;Zulma Magnani

  • Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study

    Fabio Ciceri;Chiara Bonini;Maria Teresa Lupo Stanghellini;Attilio Bondanza

  • Tumor-mediated liver X receptor-[alpha] activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses

    Eduardo J. Villablanca;Laura Raccosta;Dan Zhou;Raffaella Fontana

  • CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma

    Monica Casucci;Benedetta Nicolis di Robilant;Laura Falcone;Barbara Camisa

  • Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells

    Alessandra Biffi;Michele De Palma;Angelo Quattrini;Ubaldo Del Carro

  • Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy

    Alessandro Aiuti;Barbara Cassani;Grazia Andolfi;Massimiliano Mirolo

  • The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies.

    Catia Traversari;Sarah Marktel;Zulma Magnani;Patrizia Mangia

  • Peripheral Blood Lymphocytes as Target Cells of Retroviral Vector-Mediated Gene Transfer

    Fulvio Mavilio;Giuliana Ferrari;Silvano Rossini;Nadia Nobili

  • Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines.

    Rosa Bacchetta;Claudia Sartirana;Megan K. Levings;Claudio Bordignon

  • Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice

    Alessandra Biffi;Alessia Capotondo;Stefania Fasano;Ubaldo del Carro

Frequent Co-Authors

Chiara Bonini
Chiara Bonini Vita-Salute San Raffaele University
Fabio Ciceri
Fabio Ciceri Vita-Salute San Raffaele University
Catia Traversari
Catia Traversari MolMed (Italy)
Luca Vago
Luca Vago Vita-Salute San Raffaele University
Alessandro Aiuti
Alessandro Aiuti Vita-Salute San Raffaele University
Maria Grazia Roncarolo
Maria Grazia Roncarolo Stanford University
Luigi Naldini
Luigi Naldini Vita-Salute San Raffaele University
Maurilio Ponzoni
Maurilio Ponzoni Vita-Salute San Raffaele University
Federico Caligaris-Cappio
Federico Caligaris-Cappio Vita-Salute San Raffaele University
Armando Santoro
Armando Santoro Humanitas University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open up diverse career opportunities. Nursing roles, for instance, are popular entry points into the medical field, offering paths that complement Immunology studies.

If you're exploring options with flexible admissions, you might consider programs categorized as which LPN programs are easiest to get into. Licensed Practical Nurse (LPN) programs provide foundational clinical experience and often serve as stepping stones for further education.

For advanced practice, many students look into the easiest nurse practitioner degree programs. These programs offer streamlined curricula, allowing students to progress efficiently toward becoming nurse practitioners.

Specializing in psychiatric care is another promising direction. You can find information on the best PMHNP programs, which emphasize strong clinical placement opportunities—a crucial factor for practical experience.

Cost is also a major consideration. For those seeking budget-friendly options, the cheapest PMHNP programs provide valuable training without the heavy financial burden.

Exploring these related degrees can enhance your knowledge and skills in Immunology-related fields while providing viable career pathways in healthcare.

Best Scientists Citing Claudio Bordignon

Trending Scientists

Recently Published Articles